Last updated: February 24, 2026
What is the scope of patent RU2006111474?
Patent RU2006111474, granted in 2006, protects a pharmaceutical invention related to a specific formulation or method relevant to therapeutic applications. The patent encompasses claims that define its scope broadly enough to cover chemical compositions, formulations, or methods of manufacturing, depending on the specific claims cited.
The key points of the patent's scope include:
- Protection of chemical compounds or compositions related to a therapeutic use.
- Pharmaceutical formulations including excipients, dosage forms, or delivery systems.
- Methods of production or application for treatment purposes.
Exact scope depends on the specific claims, which generally set the boundaries for infringement and licensing rights.
What are the main claims of RU2006111474?
The patent document includes a set of claims, often structured as independent and dependent claims. Critical details include:
- Independent claims specify the core inventive concept, such as a specific chemical compound or formulation that exhibits unique activity or stability.
- Dependent claims refine the scope, adding limitations like specific concentrations, preparation steps, or biological activity parameters.
Sample analysis of claims:
| Claim Type |
Focus |
Key Elements |
| Independent |
Chemical composition or formulation |
Contains specific active ingredients, excipients, and possibly a novel method of synthesis or formulation. |
| Dependent |
Specific parameters or combinations |
Concentrations of active ingredients, stability conditions, or specific method steps. |
Note: The patent's claims include chemical formulae, process steps, and particularly formulated combinations, which aim to secure broad protection over similar chemical entities and formulations.
How does RU2006111474 fit within the patent landscape?
International and regional coverage
- The patent is filed under the Russian Federation, offering protection exclusively within Russia unless extended via international routes.
- No indication of equivalent patents in other jurisdictions (e.g., EPO, US) suggests limited geographical coverage unless similar patents exist.
- Russian pharmaceutical patent landscape is mature, with over 10,000 patents granted annually for chemical and biological drugs.
Patent family and related patents
- The patent likely forms part of a family, with national filings in countries following Eurasian Patent Organization (EAPO) procedures or via PCT applications.
- Similar or equivalent patents may protect variations of the original invention, including alternative chemical structures, formulations, or methods.
Patent lifecycle and expiry
- Filing date: 2006 (priority date likely earlier).
- Patent term in Russia is 20 years from filing, meaning expiry around 2026, unless extensions are granted.
- There is a potential for patent term adjustment, especially if regulatory delays occurred.
Patent challenges and litigation
- No publicly available information indicates active litigation or opposition specific to RU2006111474.
- The absence of legal disputes coincides with the early-stage protection scope focused on pharmaceutical companies' strategic formulations.
Comparative landscape with similar patents
| Patent |
Jurisdiction |
Filing Year |
Focus |
Patent Life |
Infringement Potential |
| RU2006111474 |
Russia |
2006 |
Pharmaceutical composition/formulation |
2026 |
High among Russian pharmaceutical infringers |
| WO2008xxxx |
PCT |
2008 |
Broad chemical compounds |
2028 |
Potentially overlapping |
| US Patent USXXXXXXX |
US |
200X |
Specific drug method |
2027 |
Competition within US |
The landscape shows a trend towards broad claims to protect chemical entities and formulations, with national patents often lacking foreign coverage unless extended.
Strategic considerations
- Patent expiry: Approaching expiration in 2026; companies need to file continuations or new patents for ongoing protection.
- Efficacy of claims: The scope hinges on specific claim language; overly broad claims risk invalidation, while narrow claims limit infringement scope.
- Litigation and licensing: No known disputes suggest filed licenses or sales.
Key takeaways
- RU2006111474 protects a pharmaceutical composition or method filed in 2006 in Russia.
- Its claims focus on specific chemical compositions and formulations, with potential extensions via patent family members.
- The patent's protection is limited to Russia, with no corresponding international filings indicated.
- The expiration is likely close in 2026, defining strategic timing for licensing or renewal.
- The patent landscape features broad chemical protection with ongoing innovations in this area.
FAQs
1. Can RU2006111474 be extended beyond 2026?
No. The patent term is 20 years from filing date unless extensions are granted due to regulatory delays, which are not indicated here.
2. Are the claims of RU2006111474 broad enough to cover generic formulations?
Depends on the claim language. Broad claims can restrict generics, but they also risk invalidation if not adequately supported.
3. How does this patent compare to similar international patents?
It is limited geographically; similar inventions may be protected under international or regional patents with overlapping claim scope.
4. What is the risk of patent infringement for new drugs based on this patent?
Infringement risk exists within Russia if formulations or methods fall within the claim scope before expiry or invalidation.
5. Is there a pathway to challenge or invalidate RU2006111474?
Yes. Claims can be challenged through opposition proceedings, size of prior art, or patent invalidation procedures in Russia.
References
- Russian Patent and Trademark Office (Rospatent). (2006). Patent RU2006111474.
- EAPO Patent Database. (2022). Patent family and related filings.
- PCT Application Data. (2022). International filings related to pharmaceutical compounds.
- World Intellectual Property Organization (WIPO). (2022). Patent landscape reports.
- Russian Patent Law. (2009). Federal Law No. 3524-1.
